Status: current, Defined. Date: 30-Apr 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3015841000168116 | Lucentis (ranibizumab 1.65 mg / 0.165 mL) injection, 1 x 0.165 mL syringe (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3015851000168119 | Lucentis 1.65 mg/0.165 mL injection, 0.165 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lucentis (ranibizumab 1.65 mg / 0.165 mL) injection, 1 x 0.165 mL syringe (trade product pack) | Is a | trade product pack | true | Inferred relationship | Some | ||
| Lucentis (ranibizumab 1.65 mg / 0.165 mL) injection, 1 x 0.165 mL syringe (trade product pack) | Is a | ranibizumab 1.65 mg/0.165 mL injection, 0.165 mL syringe | true | Inferred relationship | Some | ||
| Lucentis (ranibizumab 1.65 mg / 0.165 mL) injection, 1 x 0.165 mL syringe (trade product pack) | has TPUU | Lucentis 1.65 mg/0.165 mL injection, 0.165 mL syringe | true | Inferred relationship | Some | 1 | |
| Lucentis (ranibizumab 1.65 mg / 0.165 mL) injection, 1 x 0.165 mL syringe (trade product pack) | has TP | Lucentis | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lucentis 1.65 mg/0.165 mL injection, 0.165 mL syringe | Is a | True | Lucentis (ranibizumab 1.65 mg / 0.165 mL) injection, 1 x 0.165 mL syringe (trade product pack) | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR